Melzi Surgical to Present at the LSI USA ’22 Emerging Medtech Summit
Presentation on Friday, March 18th at 2:00 PM PTRENO, NV / ACCESSWIRE / March 18, 2022 / Melzi Surgical ("Melzi"...
News
Welcome to IRLAB’s Capital Markets Day 2022
GOTHENBURG, SWEDEN / ACCESSWIRE / March 18, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) will host a capital...
Shineco, Inc. Plans to Introduce a Private Equity Fund to Help its Business Transition
BEIJING, March 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...
Optimi Health Begins Cultivation Of Natural Psilocybin For Use In Clinical Trials
VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or...
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Final Results for SP-102 (SEMDEXA™) Efficacy and Safety from its Pivotal Phase 3 Clinical Trial Program for Sciatica Pain Management Supporting the Potential for First to Market Opportunity
SP-102 (SEMDEXA™), with 401 patients enrolled in the C.L.E.A.R. trial (Corticosteroid Lumbosacral Epidural Analgesia in Radiculopathy), experienced a rapid onset...
Nymox Announces $5 Million Registered Direct Offering
IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive...
Palisade Bio (Nasdaq: PALI) Reports Year End 2021 Financial Results and Corporate Update
CARLSBAD, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical stage biopharmaceutical...
MiNK Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
AgenT-797 (Allo-iNKTs) +/- anti-PD-1 clinical trial underway in solid tumor cancersBenefit in severe COVID-19 ARDS shows 75% survival rate in...
Align Technology Launches New Invisalign System Innovations for Orthodontic and Restorative Dental Treatment Planning with Integration of CBCT into ClinCheck Treatment Planning Software
Digitally integrating Cone Beam Computed Tomography (CBCT) scan and intraoral scan data into ClinCheck treatment plans enables doctors to confidently...
Dentsply Sirona to Participate in the Piper Sandler Virtual Dental Day
CHARLOTTE, N.C., March 18, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company...
Reviva Pharmaceuticals Holdings, Inc. to Present at Upcoming Virtual Investor Conferences
- 5th Annual Neuroscience Innovation Forum - - BIO-Europe Spring® 2022 - CUPERTINO, Calif., March 18, 2022 (GLOBE NEWSWIRE) --...
HTG Molecular Diagnostics Announces $7.5 Million Private Placement
TUCSON, Ariz., March 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose...
Immutep To Present Biomarker And Multivariate Analysis From Phase IIb AIPAC Study In Metastatic Breast Cancer At ESMO’s Breast Cancer Congress 2022
SYDNEY, AUSTRALIA, March 18, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”) is pleased...
Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525
SYDNEY, AUSTRALIA, March 18, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), is pleased...
Press Release: Sanofi moves forward with EUROAPI listing on Euronext Paris
Sanofi moves forward with EUROAPI listing on Euronext Paris Sanofi will give its shareholders the opportunity to be part...
Sibannac Inc.’s Campus Co. Platform Showing Early Signs of Success
Scottsdale, Arizona--(Newsfile Corp. - March 18, 2022) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
NoHo, Inc. Developing New Products and Begins Awareness Campaign
Scottsdale, Arizona--(Newsfile Corp. - March 18, 2022) - NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the "Company"), announced the...
Moderna Submits Amendment to the Emergency Use Authorization for an Additional Booster Dose of its COVID-19 Vaccine in the U.S.
CAMBRIDGE, MA / ACCESSWIRE / March 17, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2022
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a...
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
Reported total revenue for year end 2021 of $6.4 million representing 17% year-over-year growthEnrollment completed in U.S. pivotal PURSUIT trial...